Literature DB >> 30061296

Impact of Inducible blaDHA-1 on Susceptibility of Klebsiella pneumoniae Clinical Isolates to LYS228 and Identification of Chromosomal mpl and ampD Mutations Mediating Upregulation of Plasmid-Borne blaDHA-1 Expression.

Adriana K Jones1, Srijan Ranjitkar1, Sara Lopez1, Cindy Li1, Johanne Blais1, Folkert Reck1, Charles R Dean2.   

Abstract

Twenty-three Klebsiella pneumoniae (blaDHA-1) clinical isolates exhibited a range of susceptibilities to LYS228, with MICs of ≥8 μg/ml for 9 of these. Mutants with decreased susceptibility to LYS228 and upregulated expression of blaDHA-1 were selected from representative isolates. These had mutations in the chromosomal peptidoglycan recycling gene mpl or ampD Preexisting mpl mutations were also found in some of the clinical isolates examined, and these had strongly upregulated expression of blaDHA-1.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  DHA-1; Klebsiella; LYS228; beta-lactamases; peptidoglycan; plasmid

Mesh:

Substances:

Year:  2018        PMID: 30061296      PMCID: PMC6153798          DOI: 10.1128/AAC.01202-18

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  38 in total

Review 1.  Plasmid-determined AmpC-type beta-lactamases.

Authors:  Alain Philippon; Guillaume Arlet; George A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 3.  Outbreak of Klebsiella pneumoniae strain harbouring an AmpC (DHA-1) and a blaSHV-11 in a Belgian hospital, August-December 2006.

Authors:  T Vanwynsberghe; K Verhamme; M Raymaekers; R Cartuyvels; A Boel; H De Beenhouwer
Journal:  Euro Surveill       Date:  2007-02-01

Review 4.  Proliferation and significance of clinically relevant β-lactamases.

Authors:  Karen Bush
Journal:  Ann N Y Acad Sci       Date:  2013-01       Impact factor: 5.691

5.  Prevalence study of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking inducible ampC from Saudi hospitals.

Authors:  Baha Abdalhamid; Samar Albunayan; Alaa Shaikh; Nasreldin Elhadi; Reem Aljindan
Journal:  J Med Microbiol       Date:  2017-08-18       Impact factor: 2.472

6.  Salmonella enteritidis: AmpC plasmid-mediated inducible beta-lactamase (DHA-1) with an ampR gene from Morganella morganii.

Authors:  G Barnaud; G Arlet; C Verdet; O Gaillot; P H Lagrange; A Philippon
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

7.  In Vitro Activity of LYS228, a Novel Monobactam Antibiotic, against Multidrug-Resistant Enterobacteriaceae.

Authors:  Johanne Blais; Sara Lopez; Cindy Li; Alexey Ruzin; Srijan Ranjitkar; Charles R Dean; Jennifer A Leeds; Anthony Casarez; Robert L Simmons; Folkert Reck
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

8.  An overview of the kinetic parameters of class B beta-lactamases.

Authors:  A Felici; G Amicosante; A Oratore; R Strom; P Ledent; B Joris; L Fanuel; J M Frère
Journal:  Biochem J       Date:  1993-04-01       Impact factor: 3.857

9.  Detection and occurrence of plasmid-mediated AmpC in highly resistant gram-negative rods.

Authors:  E Ascelijn Reuland; John P Hays; Denise M C de Jongh; Eman Abdelrehim; Ina Willemsen; Jan A J W Kluytmans; Paul H M Savelkoul; Christina M J E Vandenbroucke-Grauls; Nashwan al Naiemi
Journal:  PLoS One       Date:  2014-03-18       Impact factor: 3.240

10.  Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in Pseudomonas aeruginosa.

Authors:  Peter Jorth; Kathryn McLean; Anina Ratjen; Patrick R Secor; Gilbert E Bautista; Sumedha Ravishankar; Amir Rezayat; Jayanthi Garudathri; Joe J Harrison; Rachel A Harwood; Kelsi Penewit; Adam Waalkes; Pradeep K Singh; Stephen J Salipante
Journal:  MBio       Date:  2017-10-31       Impact factor: 7.867

View more
  2 in total

1.  Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing In Vitro Susceptibility in Escherichia coli and Klebsiella pneumoniae.

Authors:  Charles R Dean; David T Barkan; Alun Bermingham; Johanne Blais; Fergal Casey; Anthony Casarez; Richard Colvin; John Fuller; Adriana K Jones; Cindy Li; Sara Lopez; Louis E Metzger; Mina Mostafavi; Ramadevi Prathapam; Dita Rasper; Folkert Reck; Alexey Ruzin; Jacob Shaul; Xiaoyu Shen; Robert L Simmons; Peter Skewes-Cox; Kenneth T Takeoka; Pramila Tamrakar; Tsuyoshi Uehara; Jun-Rong Wei
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 2.  New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae.

Authors:  Thea Brennan-Krohn; Roman Manetsch; George A O'Doherty; James E Kirby
Journal:  Transl Res       Date:  2020-03-02       Impact factor: 7.012

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.